Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins ‘Squawk Box’ to break down the quarterly earnings results of Pfizer and Merck.
Pfizer, Merk report Q4 results: Citi’s Geoff Meacham on key takeaways
Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins ‘Squawk Box’ to break down the quarterly earnings results of Pfizer and Merck.